Join to View Full Profile
785 Medical Center Drive West203Fresno, CA 93611
Phone+1 559-387-1900
Fax+1 559-387-1950
Dr. Abdulhaq is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Allegheny Health Network Medical Education Consortium (WPH/AGH)Fellowship, Hematology and Medical Oncology, 2005 - 2008
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2002 - 2005
- Damascus University Faculty of MedicineClass of 1998
Certifications & Licensure
- CA State Medical License 2010 - 2026
- PA State Medical License 2002 - 2010
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Novel Combination Therapy With Lenalidomide and Trametinib for Treatment-Resistant Xanthoma Disseminatum With Disabling Cutaneous and Synovial Involvement: A Case Report.Sundeep Bekal, Haifaa Abdulhaq
Cureus. 2025-05-01 - 18 citationsGlofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, random...Jeremy S Abramson, Matthew Ku, Mark Hertzberg, Hui-Qiang Huang, Christopher P Fox
Lancet. 2024-11-16 - 7 citationsProgression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm.Charlotte Pawlyn, Fredrik H Schjesvold, David A Cairns, L J Wei, Faith Davies
Blood Cancer Journal. 2024-08-12
Press Mentions
- New Two-Year Follow-up of Roche’s Columvi Extends Overall Survival in Relapsed or Refractory Diffuse Large B-cell Lymphoma PatientsMay 22nd, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: